[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity

robot
Abstract generation in progress

Quest Diagnostics Executive Vice President & CFO Sam Samad reported an acquisition of 108 common shares on April 20, 2026, at $194.698 per share. This transaction, involving restricted share units and a dividend reinvestment plan, increased his direct holdings to 33,376 shares. The filing indicates Samad chose to report this early on Form 4, rather than deferring to a Form 5.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin